Ioflupane I-123 Withdrawn Phase 3 Trials for Parkinson's Disease (PD) Diagnostic

IndicationsStatusPurposePhase
WithdrawnDiagnostic3
clinicaltrials.gov IdentifierTitleDrugs
NCT01950468A Cross-Over, Multi-Center Trial to Evaluate the Diagnostic Efficacy and Safety of [123I]NAV5001 as an Imaging Agent to Aid in the Diagnosis of Parkinsonian Syndromes